Definitive Contract HHSN261201300072C
Award Date 9/25/13
Potential Completion Date 11/24/14
Potential Value $200K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Rockville, MD 20850, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
16
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a $983,105.58 definitive contract awarded by the National Cancer Institute (NCI) to Origene Technologies, Inc. to provide "HIGH AFFINITY SISCAPA ANTIBODIES". The contract is a cost-no-fee arrangement with a completion date of September 21, 2018. Origene Technologies is a for-profit organization that specializes in providing research reagents such as cDNA clones, antibodies, and proteins to government agencies, including the Department of Veterans Affairs. While no set-aside was...
- This is a $15,150 firm fixed price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID) to Origene Technologies, Inc. for cDNA sequencing services. The contract was awarded without any set-aside and has a completion date of September 10, 2014. Origene Technologies, Inc. is a for-profit organization that provides a range of life science research products and services, including cDNA clones, antibodies, and assays. Through prior prime contracts with the...
- This is a firm fixed price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the U.S. Department of Health and Human Services, to Integrated Genomics, Inc. for ORF identification, annotation, and ERGO update services. The contract has a ceiling value of $11,999.90 and was awarded on October 29, 2010 with a final completion date of December 30, 2010. The contract does not have a set-aside designation. Based on the agency and...
- <p>This is a $299,999.00 Firm Fixed Price contract awarded by the National Cancer Institute, a civilian agency, to Innogenomics Technologies, L.L.C., a minority-owned small business, under the Small Business Innovation Research (SBIR) Program Phase I. The contract is for research and development in the area of biomedical (basic research). It was awarded on September 22, 2015 with a final completion date of March 21, 2017. The contract has a total small business set-aside designation.</p>
- This is a $199,828 Firm Fixed Price contract awarded by the National Cancer Institute (NCI), a component of the Department of Health and Human Services, to A&G Pharmaceutical, Inc. (doing business as Precision Antibody) for the development of "TECHNOLOGY GENERATED ANTI-PEPTIDE CAPTURE REAGENTS FOR AFFINITY ENRICHED PROTEOMIC STUDIES." The contract has a performance period ending on July 24, 2014 and was awarded on September 25, 2013. Precision Antibody is a for-profit...
- This is a federal contract awarded by the National Cancer Institute (NCI), a component of the U.S. Department of Health and Human Services (HHS), to A&G Pharmaceutical, Inc. (doing business as Precision Antibody). The $199,380 firm-fixed-price contract is for research and development related to biomedical products and was awarded on September 14, 2012, with a completion date of September 13, 2013. The contract does not have a set-aside designation. A&G Pharmaceutical, Inc. is a...
- This contract was awarded by the National Cancer Institute (NCI), a civilian agency within the Department of Health and Human Services, to Life Technologies Corporation, a for-profit manufacturer of scientific instruments, reagents, and consumables. The $14,915.36 Blanket Purchase Agreement (BPA) call order is for firm-fixed-price products and services, with an ultimate completion date of February 22, 2016. Life Technologies has served as a prime contractor across multiple federal agencies,...
- This is a $6,047.50 firm fixed price BPA call contract awarded by the National Cancer Institute (NCI), a civilian agency within the Department of Health and Human Services, to Life Technologies Corporation. The contract provides for the delivery of Invitrogen-branded scientific instruments, reagents, and consumables to support the NCI's biomedical research and healthcare initiatives. Life Technologies serves as a prime contractor for the NCI through various contract types, leveraging its...
- This federal contract was awarded by the National Cancer Institute (NCI), a civilian agency within the National Institutes of Health (NIH), to A&G Pharmaceutical, Inc. (also known as Precision Antibody), a for-profit manufacturer of biological materials and research services. The contract, valued at $999,685.00, is for the development of "SMART FUSION: HIGH AFFINITY PEPTIDE CAPTURE REAGENTS" and has a period of performance through March 31, 2018. The contract type is a Definitive...
- This federal contract award to Life Technologies Corporation, a manufacturer of scientific instruments, reagents, and consumables, is a Firm Fixed Price Purchase Order from the Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases. The contract, which does not have a set-aside designation, has a potential value of $17,110.91 and a completion date of April 16, 2024. As a prime contractor, Life Technologies Corporation...